Fortress Biotech (FBIO)
(Delayed Data from NSDQ)
$3.67 USD
+0.11 (3.09%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $3.66 -0.01 (-0.27%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Fortress Biotech, Inc. has a market cap of $105.93M, which represents its share price of $3.56 multiplied by its outstanding shares number of 29.75M. As a small-cap company, FBIO's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
FBIO 3.67 +0.11(3.09%)
Will FBIO be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for FBIO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FBIO
Fortress Biotech (FBIO) Reports Q2 Loss, Beats Revenue Estimates
Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates
FBIO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Coherus Oncology (CHRS) Reports Q2 Loss, Beats Revenue Estimates
Why Fast-paced Mover Fortress Biotech (FBIO) Is a Great Choice for Value Investors
Ultragenyx (RARE) Surges 5.1%: Is This an Indication of Further Gains?
Other News for FBIO
FBIO forms MACD Bearish Signal Line Cross on September 19
FBIO's price rises by 3.49% on September 18, though its technical setup remains stable.
NR7 appears for FBIO after 0.29% move
FBIO's price falls by 3.38% on September 16, though its technical setup remains stable.
Is FBIO poised for gains? Slingshot Bullish shows up after crashing 8.74%